Uncategorized
Oraya Therapy maintains vision, reduces injections in wet AMD treatment at 1 year
Oraya Therapy maintained vision and reduced the number of anti-VEGF injections in the treatment of wet age-related macular degeneration, according to an Oraya Therapeutics press release.The 1-year results, presented at the Euretina meeting, showed chronic patients had a 40% to 74% reduction in the number of injections with a significant decrease in macular edema. Newly diagnosed patients experienced significantly better vision compared with those in a historical control group.